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An Editorial on
Monocyte Heterogeneity and Function
Monocytes originate from bone marrow hematopoietic stem cells and circulate in the
bloodstream. Monocyte extravasation and differentiation serve multiple immune functions.
The differentiation of monocytes into tissue macrophages at steady state can serve homeostatic
functions. Monocytes can also fuel acute inflammatory reactions and anti-microbial immunity by
differentiating into inflammatory macrophages. Finally, monocytes also actively contribute to the
resolution of inflammation and tissue regeneration.
The subset classification of monocytes is a rapidly emerging field. Recent progress in single-cell
genomics and high dimensional approaches in phenotyping have highlighted additional subsets of
monocytes. Monocytes might also adopt new dynamic transcriptional states associated with
inflammation and reflecting their subset heterogeneity. This brings the research community to
face a significant challenge of assigning monocyte heterogeneity to specific functions. The goal of
this Research Topic is to gather contributions bringing new insights into:
i. Monocyte subsets and their ontogeny
ii. Monocyte heterogeneity and inflammatory diseases
iii. Monocyte heterogeneity and the regulation of inflammation
iv. Monocyte heterogeneity and cancerorg January 2021 | Volume 11 | Article 6267251
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ONTOGENY
Kapellos et al. provide an updated classification of human
monocytes by compiling multiple profiling studies 1.
Monocytes are composed of two main subsets: CD14+ and
CD16+ monocytes in humans and Ly6Chigh and Ly6Clow
monocytes in mice.
While originally referred to as “inflammatory” monocytes,
Ly6Chigh and CD14+ monocytes are now termed “classical”
monocytes. Although classical monocytes constitutively enter
tissues during homeostasis, upon inflammation, they rapidly
extravasate and, depending on the needs of the environment,
can differentiate into multiple cell types such as monocyte-
derived macrophages.
CD16+ and Ly6Clow monocytes are termed as “non-classical”
(Kapellos et al.). Non-classical monocytes display an intra-
vascular function, interacting dynamically with endothelial
cells (1). In humans, the existence of “intermediate”
CD14+CD16+ monocytes complicates the distinction of
“classical” vs. “non-classical” (Kapellos et al.). Expression of 6-
sulfo LacNac sugar antigen linked to the cell surface protein
PSGL-1 is termed as SLAN. SLAN expression defines non-
classical CD16+ in humans and provides a practical way to
distinguish them from the “intermediate” CD14+CD16+
monocytes (Hofer et al.).
The developmental pathways by which monocytes arise from
hematopoietic stem cells have received a lot of attention. Since
the identification and characterization of Granulocyte-Monocyte
Progenitors by Akashi et al. in 2000 (2), the ontogenetic
pathways of monocytes have been continuously revisited.
Geissmann et al. identified progenitors endowed with a mixed
potential for monocytes and dendritic cells but devoid of
granulocyte potential (3).
In this topic, Wolf et al. review the current line of evidence
supporting the existence of multiple differentiation pathways for
monocytes (Wolf et al.). GMP-dependent monocytes would co-
exist with MDP-derived monocytes. The later encompass
monocytes progenitors endowed with a potential for the
generation of monocyte-derived DCs (moDCs). Fate mapping
studies with Ms4a3cre/Ms4a3CreERT2 driver lines identifies the
GMP-dependent pathway for the generation of monocytes and
assesses precisely its contribution to the tissue resident
macrophages (TRMs) pool (4).
The differentiation of monocytes into cellular products
endowed with DC-like features has been historically evidenced
in vitro (5). Since then, multiple lines of evidence suggest the
physiological relevance of this process. In this topic, Coillard
et al. review the current evidence suggesting that moDCs actually
accumulate in patho-physiological conditions with important
outcomes for the exacerbation or regulation of inflammation
(Coillard and Segura).
Duroux-Richard et al. summarize the current of knowledge
on the regulation of monocytes subsets by microRNAs. For
instance, mir146a regulate the pool of classical monocytes with
a regulatory role in osteoclastogenesis (Duroux-Richard et al.).Frontiers in Immunology | www.frontiersin.org 2Assessing developmental pathways underlying the production
of monocyte subsets during homeostasis should not obliterate
the fact that monocytes are highly dynamic and regulated by
both environmental and genetic factors (Kapellos et al.; Patel and
Yona). In this topic, Patel et al. and Kapellos et al. provide a
fascinating inventory of factors impacting on monocyte
populations thereby emphasizing that “steady state is not a
single physiological condition” (Patel and Yona) and providing
some insights on how changes in lifestyle impact on monocyte
subsets (Kapellos et al.).
Deciphering the aegis of specific signals is often complicated
by the fact that they act not only on monocytes but also on
numerous other myeloid lineages. The inflammatory factor GM-
CSF provides a good example of such pleiotropy. Zhan et al.
delineate the complex effects on GM-CSF on myeloid lineages
and highlight how signal dosage impacts on signaling outcomes
and biological functions. Specifically, low doses of GM-CSF
activate preferentially the PI3K/Akt while higher doses of
GM-CSF are needed to activate the JAK2/STAT5 pathway
(Zhan et al.).MONOCYTE HETEROGENEITY
AND INFLAMMATORY DISEASES
Monocyte subsets represent both circulating precursors and
effector populations in the bloodstream or within tissues
(Kapellos et al.) (6). For instance, Ly6Clow and CD16+
monocytes mainly display an intra-vascular function,
interacting dynamically with endothelial cells (Hofer et al.) (1).
Kapellos et al. extensively review evidences highlighting the
modification of the compartment of monocyte associated to
COPD, or atherosclerosis for instance.
Monocyte extravasation supports their function of precursors
for macrophages. In particular, Dick et al. provide an integrative
picture of the remodeling of cardiac macrophages populations
imposed by ischemic injury. Some striking features emerging
from multiple scRNAseq studies might apply to various cases of
acute injury: i) TIMD4+LYVE1+MHCIIlow TRMs tissue resident
macrophages rapidly disappear from the inflamed zone but
slowly repopulate the organ by local proliferation; ii) monocyte-
derived macrophages acquire multiple transcriptional phenotypes
including one resembling tissue resident macrophages (despite the
absence of TIMD4 and LYVE1 expression) and other transcriptional
phenotypes possibly associated to tissue repair functions; iii)
TIMD4+LYVE1+MHCIIlow and CCR2+ TRMs pools present
before the onset of acute injury orchestrate monocyte infiltration
by controlling the diversity of inflammatory macrophages
phenotypes with important consequences for the onset of tissue
repair (Dick et al.). Further research is needed to establish a map of
developmental trajectories linking monocyte subsets to macrophages
recruited after myocardial injury, possibly involving a heterogenous
spatial distribution (Dick et al.). Coillard and Segura detail and
discuss the various markers and methodological options available, in
human immunology settings, to probe the monocytic origin of tissueJanuary 2021 | Volume 11 | Article 626725
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the analysis of macrophage dynamics in the injured myocardium
underlines the difficulties to move beyond the transcriptional
definition of cellular populations to an integrated understanding of
their functional contributions to both injury and tissue repair
(Dick et al.).
Monocytes and macrophages play a major role in autoimmunity.
In this topic, Ma et al. provide a broad panorama of the role of
monocytes in multiple autoimmune conditions ranging from
Systemic Lupus Erythematosus (SLE) to type 1 diabetes (T1D).
Understanding monocyte biology has important therapeutic
application. In this context, Hamilton delivers a synthesis of the
current knowledge and controversies regarding the action of GM-
CSF on monocytes and macrophages. A key feature of GM-CSF
signaling lies in the activation of the CCL17 axis inmonocyte-derived
macrophages by a process involving the JMJD3 histone demethylase.
Therapeutic blockade of GM-CSF in rheumatoid arthritis reduce
CCL17 levels and reduces osteoarthritic pain (Hamilton).MONOCYTE HETEROGENEITY AND THE
REGULATION OF INFLAMMATION
The role of monocyte subsets in the resolution of inflammation is
increasingly considered. The differentiation of classical
monocytes into microbicidal macrophages is a central feature
of anti-infectious innate immunity (7). However, this axis needs
to be tightly regulated since microbicidal function can be
associated to tissue damage. Postat and Bousso identify
quorum sensing as new mechanism to maintain tissue integrity
during the onset of anti-microbial innate immune reactions. In
this case, nitric oxide release by differentiated anti-microbial
monocytes plays a major role in activating the resolution of
inflammation by a mechanism involving the suppression of
mitochondrial respiration, thereby limiting cytokine and
chemokine secretion (Postat and Bousso). Furthermore, IL-10
is also an important immuno-regulatory factor that can promote
the acquisition of an immunoregulatory phenotype in differentiated
moDCs associated to CD14 re-expression when combined with
TLR stimulation (Krakow et al.). Undoubtedly, that understanding
the mechanisms generating monocyte-derived cells endowed
with immunosuppressive properties has a strong therapeuticFrontiers in Immunology | www.frontiersin.org 3relevance. For instance, Iglesias-Escudero et al. show in this
topic that the presence of regulatory monocytes descendants is
regulated by rapamycin in kidney transplant recipients.
The resolution of inflammation is a dynamic process relying on
the efferocytic capacity of monocytes and their progeny, which
support the development of anti-inflammatory responses and
subsequently will contribute to the reestablishment of tissue
resident macrophage pool. In this regard, Butenko et al.
evidence that post-phagocytic “satiated” monocyte-derived
macrophages express type I IFN and exhibit a transcriptomic
profile limiting their pro-fibrogenic activity.MONOCYTE HETEROGENEITY
AND CANCER
Monocytes play a major role in cancer where CCR2-dependent
classical inflammatory monocytes largely contribute to the pool
of tumor-associated macrophages (TAMs), often with
immunosuppressive and pro-tumoral properties (8). By
contrast, non-classical monocytes had been shown to limit the
metastatic spread of tumors through the blood circulation (9).
Wu et al. discuss the relevance and limitations of the M1/M2
paradigm to understand the diversity of transcriptional states
observed in TAMs. Wu et al. propose to re-assess TAM
heterogeneity by integrating their ontogeny, activation and
localization. Laviron and Boissonnas review the current
knowledge on the selective contributions and functional
contributions of acutely recruited monocytes in cancer versus
pre-existing homeostatic tissue resident macrophage would they
be derived from embryonic precursors or adult monocytes.
In summary, the very diverse and multidisciplinary
contributions in this Frontiers TOPIC highlight the dynamism
of monocyte research in finding new developments related to
multiple biological processes and pathologies.AUTHOR CONTRIBUTIONS
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